Clicky

Genprex, Inc.(GNPX)

Description: Genprex Inc is a clinical stage gene therapy company. It develops therapies that carry cancer-fighting genes. Its initial product candidate is Oncoprex.


Keywords: Medicine Biotechnology Cancer Biology Gene Therapy Medical Genetics Medicinal Chemistry Applied Genetics

Home Page: www.genprex.com

GNPX Technical Analysis

3300 Bee Cave Road
Austin, TX 78746
United States
Phone: 877 774 4679


Officers

Name Title
Mr. John Rodney Varner Co-Founder, Chairman, Pres & CEO
Mr. Ryan M. Confer M.S. Chief Financial Officer
Ms. Catherine M. Vaczy Esq. Exec. VP, Gen. Counsel, Corp. Sec. & Chief Strategy Officer
Dr. Hemant Kumar C.P.M., EMBA, Ph.D. Chief Manufacturing & Technology Officer
Ms. Kalyn Dabbs Sr. Mang. of Communications & Marketing
Mr. David M. Schloss Sr. VP of HR
Mr. Thomas C. Gallagher Esq. Sr. VP of Intellectual Property & Licensing
Dr. William E. Gannon Jr. Member of Clinical Advisory Board & VP of Regulatory Affairs
Dr. Mark S. Berger M.D. Chief Medical Officer
Mr. Greg Jancarik C.M.A., CPA, M.B.A. Corp. Controller

Exchange: NASDAQ

Country: US

Currency: US Dollar ($)

Forward PE: 0
Trailing PE: 0
Price-to-Book MRQ: 2.0266
Price-to-Sales TTM: 0
IPO Date: 2018-03-29
Fiscal Year End: December
Full Time Employees: 22
Back to stocks